HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy-Reference-Cited by-同舟云学术

HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy

Published:2016-08-30 Issue:40 Volume:7 Page:64820-64835
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mehta Meghna¹,Basalingappa Kanthesh¹,Griffith James N.¹,Andrade Daniel¹,Babu Anish²³,Amreddy Narsireddy²³,Muralidharan Ranganayaki²³,Gorospe Myriam⁴,Herman Terence¹,Ding Wei-Qun²,Ramesh Rajagopal²³⁵,Munshi Anupama¹³

Affiliation:

1. Department of Radiation Oncology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

2. Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

3. Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

4. National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA

5. Graduate Program in Biomedical Sciences, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer;Neoplasia;2024-11

2. Human antigen R: Exploring its inflammatory response impact and significance in cardiometabolic disorders;Journal of Cellular Physiology;2024-03

3. Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR;Translational Cancer Research;2023-12

4. Targeting the RNA-Binding Protein HuR in Cancer;Cancer Research;2023-09-08

5. Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins;Pharmaceuticals;2023-08-07